Avondale Pharms Drug Patent Portfolio
Avondale Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Avondale Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6184220 | Oral suspension of pharmaceutical substance | 25 Sep, 2019 | Expired |
| US6184220 | Oral suspension of pharmaceutical substance | 25 Mar, 2019 | Expired |
Latest Legal Activities on Avondale Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Avondale Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 07 May, 2021 | US9808468 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Mar, 2021 | US8545879 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 16 Nov, 2020 | US9649318 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 16 Oct, 2020 | US9649318 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 29 Jun, 2020 | US9526734 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 22 May, 2020 | US9526734 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Nov, 2017 | US9808468 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Nov, 2017 | US9808468 |
|
Email Notification
Critical
| 19 Oct, 2017 | US9808468 |
|
Issue Notification Mailed
Critical
| 18 Oct, 2017 | US9808468 |
| Dispatch to FDC | 29 Sep, 2017 | US9808468 |
|
Application Is Considered Ready for Issue
Critical
| 29 Sep, 2017 | US9808468 |
|
Issue Fee Payment Verified
Critical
| 27 Sep, 2017 | US9808468 |
|
Issue Fee Payment Received
Critical
| 27 Sep, 2017 | US9808468 |
| Response to Reasons for Allowance | 27 Sep, 2017 | US9808468 |
Avondale Pharms's Family Patents
Avondale Pharms Drug List
Given below is the complete list of Avondale Pharms's drugs and the patents protecting them.
1. Meloxicam
Meloxicam is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6184220
(Pediatric)
| Oral suspension of pharmaceutical substance |
25 Sep, 2019
(5 years ago)
| Expired |
| US6184220 | Oral suspension of pharmaceutical substance |
25 Mar, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Meloxicam's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List